Literature DB >> 1324177

Hepatitis C virus antibodies in a long-term follow-up of beta-thalassaemic children with acute and chronic non-A non-B hepatitis.

M Resti1, C Azzari, M E Rossi, C Vullo, E Zammarchi, A Vierucci.   

Abstract

The presence of antibodies toward hepatitis C virus (HCV) was examined in 78 polytransfused beta-thalassaemic children. The anti-HCV status was correlated with acute and chronic non-A non-B (NANB) hepatitis that developed during a follow up of about 13 years. Anti-HCV was present in 83.3% of children with acute NANB hepatitis and in 82.9% of those with chronic NANB hepatitis. The percentage of chronic evolution was 56.7% for acute anti-HCV positive NANB hepatitis and 50.0% for anti-HCV negative NANB hepatitis. The long-term persistence of anti-HCV antibodies did not correlate with chronic evolution of liver infection in thalassaemic patients. Histological features of chronic hepatitis showed little or no difference between HCV associated or non-associated liver disease. The multifactorial liver injury in beta-thalassaemic children explains the high prevalence of cirrhosis (about 30%) observed in these patients with NANB hepatitis. On the other hand, independent of liver disease, some patients never seroconverted during the follow up in spite of the high number of transfusions suggesting the existence of "non-responders".

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324177     DOI: 10.1007/bf01957724

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  25 in total

1.  Hepatitis C infection in multitransfused patients with acute leukaemia.

Authors:  M F Murphy; A H Waters; P C Grint; A E Hardiman; T A Lister
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321

2.  Intrafamilial transmission of hepatitis C virus.

Authors:  H Kamitsukasa; H Harada; M Yakura; A Fukuda; A Ohbayashi; I Saito; T Miyamura; Q L Choo; M Houghton; G Kuo
Journal:  Lancet       Date:  1989-10-21       Impact factor: 79.321

3.  Australia antigen and antibody in transfused children with thalassaemia.

Authors:  A Vierucci; W T London; B S Blumberg; A I Sutnick; F Ragazzini
Journal:  Arch Dis Child       Date:  1972-10       Impact factor: 3.791

4.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

Review 5.  Non-A, non-B hepatitis: evolving epidemiologic and clinical perspective.

Authors:  J L Dienstag; H J Alter
Journal:  Semin Liver Dis       Date:  1986-02       Impact factor: 6.115

6.  Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands.

Authors:  C L van der Poel; H W Reesink; P N Lelie; A Leentvaar-Kuypers; Q L Choo; G Kuo; M Houghton
Journal:  Lancet       Date:  1989-08-05       Impact factor: 79.321

7.  Posttransfusion non-A, non-B hepatitis: physicochemical properties of two distinct agents.

Authors:  D W Bradley; J E Maynard; H Popper; E H Cook; J W Ebert; K A McCaustland; C A Schable; H A Fields
Journal:  J Infect Dis       Date:  1983-08       Impact factor: 5.226

Review 8.  Post-transfusion hepatitis: current perspectives.

Authors:  R D Aach; R A Kahn
Journal:  Ann Intern Med       Date:  1980-04       Impact factor: 25.391

9.  Changes in superoxide anion production in neutrophils from multitransfused beta-thalassemia patients: correlation with ferritin levels and liver damage.

Authors:  M de Martino; M E Rossi; M Resti; C Vullo; A Vierucci
Journal:  Acta Haematol       Date:  1984       Impact factor: 2.195

10.  Chronic viral hepatitis in thalassemic liver disease. A long-term study in patients with acute hepatitis with nontransfusion-dependent thalassemia minor.

Authors:  G Pastore; N Tannoia; G Angarano; L Monno; T Santantonio; A Pietrapertosa; G Malcangi; A Putignano; O Schiraldi
Journal:  Vox Sang       Date:  1983       Impact factor: 2.144

View more
  5 in total

Review 1.  Hepatitis C in childhood.

Authors:  F Bortolotti
Journal:  Indian J Pediatr       Date:  1995 Sep-Oct       Impact factor: 1.967

Review 2.  Hepatitis B, C & D viral markers in multitransfused thalassemic children: long-term complications and present management.

Authors:  V P Choudhry; S K Acharya
Journal:  Indian J Pediatr       Date:  1995 Nov-Dec       Impact factor: 1.967

3.  Is liver involvement of beta thalassaemic children related to the presence of hepatitis C virus antibodies?

Authors:  S Ozsoylu
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183

4.  Prevalence and clinical features of cryoglobulinaemia in multitransfused beta-thalassaemia patients.

Authors:  R Perniola; C De Rinaldis; E Accogli; G Lobreglio
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

5.  Incidence and morbidity of infection by hepatitis C virus in children with acute lymphoblastic leukaemia.

Authors:  S P Dibenedetto; R Ragusa; A Sciacca; A Di Cataldo; V Miraglia; S D'Amico; L Lo Nigro; A M Ippolito
Journal:  Eur J Pediatr       Date:  1994-04       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.